Non-executive director Guo Huaqing increased his holding of Keji Pharmaceutical (02171) by 30,000 shares at a price of HK$15.09 per share.
On December 19, non-executive director Guo Huaqing increased his holdings of Koji Pharmaceuticals (02171) by 30,000 shares, with a unit price of 15.09 Hong Kong dollars, for a total amount of 452,700 Hong Kong dollars.
The latest data from the Hong Kong Stock Exchange showed that on December 19, non-executive director Guo Huaqing increased his stake in Keji Pharmaceutical (02171) by 30,000 shares, priced at HK$15.09 per share, with a total amount of HK$452,700. After the increase, the latest number of shares held is approximately 226 million shares, with a shareholding percentage of 39.02%.
Related Articles
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
